|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-NeurosciencesRadiotracers - Receptors and Transporters |
1 Radiology, University of Pennsylvania, Philadelphia, Pennsylvania; 2 Avid Radiopharmaceuticals, Inc., Philadelphia, Pennsylvania; 3 Radiology, University of Michigan, Ann Arbor, Michigan
567
Objectives: Vesicular monoamine transporter 2 (VMAT2) is highly expressed in the beta cells of the pancreatic islets. We have recently reported a F-18 9-fluoropropyl-(+)dihydrotetrabenazine, (+)FP-DTBZ showing excellent in vitro and in vivo properties for imaging pancreatic beta cell mass. To improve the beta cell selectivity we report F-18 epoxide derivative of DTBZ (at the C2 position) as a new improved imaging agent for beta cell mass.
Methods: Both F-18 and F-19 (+) and (-)-epoxide FP-DTBZ were prepared. Organ distribution was carried out in normal rats. Uptake of F-18 (+)-epoxide FP-DTBZ in pancreas of normal rats was measured and correlated with blocking study using cold (+)-DTBZ or (+)FP-DTBZ.
Results: In vitro binding study of VMAT2 using rat brain striatum showed a Ki value of 0.08 and 30 nM for the (+) and (-)-epoxide FP-DTBZ. The in vivo biodistribution of F-18 (+)-epoxide FP-DTBZ in rats showed the highest uptake in the pancreas (2.85 % dose/g at 30 min post-injection). In vivo competition experiments with cold (+)-DTBZ led to a significant reduction (62 % blockade) when rats were pretreated with (+)DTBZ (3.3 mg/kg). The inactive isomer, F-18(-)-epoxide FP-DTBZ, showed a significantly lower pancreas uptake (0.22 % dose/g at 30 min post-injection). Blocking study of the inactive isomer showed no change in pancreas uptake.
Conclusions: The preliminary data observed with F-18(+)-epoxide FP-DTBZ indicate that this F-18 tracer for VMAT2 has high selective uptake and it may be potentially useful for imaging beta cell mass.
Research Support: Supported by a grant from Avid Radiopharmaceuticals, Inc.
| ||||||||||||||||||||||||||||||||||||||